Breast Cancer

Breast Cancer, explained simply

Everything a patient or caregiver wants to understand: what breast cancer is, how doctors describe its stage, the standard treatment plan, how radiation works, and the research shaping care today.

On this page

Watch: the CureRays® explainer series

Watch Dr. Hess explain radiation therapyPlain-language videos on how radiation works, what treatment feels like, and what to expect — on the CureRays® YouTube channel.

Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.

What is breast cancer?

The breast is made of ducts that carry milk and lobules that make it. Breast cancer starts when cells lining these structures grow uncontrollably, forming a lump that can invade nearby tissue and, over time, spread elsewhere. Found early, the 5-year survival rate is about 99%.

In one line: Breast cancer begins when cells in the breast's ducts or lobules grow out of control; caught early, it is highly treatable.

The main types

Doctors group breast cancer by where it starts and how it behaves:

TypeWhat it means, simply
DCIS (ductal carcinoma in situ)The earliest, stage 0 form — abnormal cells still inside a milk duct.
Invasive ductal carcinomaMost common type; started in a duct and grew into surrounding tissue.
Invasive lobular carcinomaStarted in a milk-making lobule; can be harder to feel as a lump.
Triple-negative & HER2-positiveSubtypes defined by lab tests that guide which medicines work best.

Staging, in plain terms

Staging describes how much cancer there is and where it has gone, using T (tumor size), N (lymph nodes), and M (metastasis/distant spread).

TNMWhat it generally means
Stage 0Pre-invasive (DCIS). Abnormal cells confined inside a duct. Very high cure rate.
Stage IA small invasive cancer (up to ~2 cm) with little or no lymph-node involvement.
Stage IIA larger tumor and/or a few nearby lymph nodes, still confined to the breast area.
Stage IIILocally advanced — larger and/or more nodes involved, not yet in distant organs.
Stage IVMetastatic — spread to distant organs. Treatable and manageable, often for years.
Plain-language takeaway: Staging tells your team how much disease there is and where — but your tumor's biology matters too. Two people described the same way can still have different plans, and that's a good thing.

The standard of care

Breast Cancer is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:

Surgery

Lumpectomy (remove the tumor, keep the breast) or mastectomy (remove the whole breast); lymph nodes are often sampled.

Radiation therapy

After lumpectomy, radiation lowers the chance the cancer returns — the standard partner to breast-conserving surgery.

Systemic medicine

Hormone-blocking pills, chemotherapy, and/or targeted drugs (like HER2 therapy) based on tumor biology.

How radiation treatment works

Radiation uses focused high-energy x-rays to damage cancer-cell DNA so the cells can no longer divide. Healthy cells repair this damage better than cancer cells, so fractionated treatment clears cancer while sparing normal tissue. Sessions are painless and brief; the main side effects are a sunburn-like skin reaction and some fatigue that settle after treatment.

The main ways radiation is delivered for breast cancer:

Whole-breast irradiation (WBI)

Treats the whole breast after lumpectomy. Standard today is hypofractionation — slightly larger daily doses over ~3 weeks (e.g., 40 Gy in 15 fractions).

Accelerated partial-breast irradiation (APBI)

Targets only the area around the tumor bed for select early cancers, over 1-2 weeks, with fewer side effects.

Advanced external-beam (IMRT/IGRT/breath-hold)

Shapes and aims the dose precisely; breath-hold moves the heart away for left-sided cancers.

Latest studies shaping care

Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:

LUMINA (2022, 10-yr data 2025): Women 55+ with small low-risk luminal-A cancers on hormone therapy could safely skip radiation — only 2.3% local recurrence at 5 years.[1]

The Oncologist (2025) · PMID 37585627 (opens in a new tab)

PRIME II (10-year results): Omitting radiation in women 65+ with small hormone-receptor-positive cancers did not affect survival, with about a 10% in-breast recurrence at 10 years.[2]

PRIME II randomized trial · PMID 36791159 (opens in a new tab)

Hypofractionation as standard: NCCN and ASTRO now prefer shorter hypofractionated whole-breast radiation — fewer visits, equal control, comparable cosmetics.[3]

NCCN / ASTRO guidelines

Common questions

Will radiation make me radioactive? No. External-beam radiation passes through and leaves no radioactivity. You are safe around family, including children.

How many treatments will I need? Often 15-20 short daily sessions over about 3 weeks, and sometimes fewer with partial-breast approaches.

Can I keep working? Most people continue normal activities, fitting brief daily visits around their day.

References

Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.

  1. Whelan TJ, Smith S, Parpia S, Fyles AW, Bane A, Liu FF, et al. Omitting radiotherapy after breast-conserving surgery in luminal A breast cancer. N Engl J Med. 2023;389(7):612-619. (opens in a new tab) PMID 37585627
  2. Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM. Breast-conserving surgery with or without irradiation in early breast cancer. N Engl J Med. 2023;388(7):585-594. (opens in a new tab) PMID 36791159
  3. NCCN / ASTRO guidelines (no indexed identifier — see your care team)
Medical disclaimer: This guide is general patient education, not medical advice, and reflects widely accepted standards as of 2026. Your situation is unique — always discuss your diagnosis and options with your own care team. CureRays clinicians are here to help you understand your choices.

Talk to a CureRays radiation oncologist Back to all guides